Engineers Gate Manager LP Invitae Corp Transaction History

Engineers Gate Manager LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.6 - $1.53 $26,477 - $67,517	44,129 New	44,129 $26,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $42,582 - $96,874	35,485 Added 191.01%	54,063 $72,000
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $31,768 - $67,066	18,578 New	18,578 $34,000
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $35,492 - $150,133	-16,663 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $2,386 - $5,924	380 Added 2.33%	16,663 $133,000

Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $239,360 - $466,833	16,283 New	16,283 $249,000
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $1.23 Million - $1.7 Million	-50,471 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $1.1 Million - $1.7 Million	41,971 Added 493.78%	50,471 $1.7 Million
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $281,010 - $483,905	8,500 New	8,500 $325,000
Q1 2020 May 15, 2020	SELL	$7.64 - $27.5 $152,479 - $548,845	-19,958 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$15.02 - $20.57 $299,769 - $410,536	19,958 New	19,958 $322,000
Q3 2019 Nov 14, 2019	SELL	$18.85 - $27.5 $781,275 - $1.14 Million	-41,447 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$17.37 - $26.27 $719,934 - $1.09 Million	41,447 New	41,447 $974,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.